 JERUSALEM , Nov. 21, 2022 PRNewswire -- BiondVax Pharmaceuticals Ltd. Nasdaq: BVXV BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, announced today that its CEO Amir Reichman will present at the January 9-11, 2023 Biotech Showcase conference. 